Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Praxis Precision Medicines, Inc. Director's Dealing 2021

Apr 15, 2021

32153_dirs_2021-04-15_65f8d9fb-87a8-4891-a6ed-c97472637ad7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Praxis Precision Medicines, Inc. (PRAX)
CIK: 0001689548
Period of Report: 2021-04-13

Reporting Person: Chodakewitz Jeffrey (Director)

More from Praxis Precision Medicines, Inc.

Regulatory Filings 2026
Jun 1
Regulatory Filings 2026
May 13
Interim / Quarterly Report 2026
May 7
Regulatory Filings 2026
Apr 14
Annual Report 2026
Feb 19
Regulatory Filings 2026
Feb 19
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 12
View all filings →